Published on Web 05/05/2010
Silver Nanoparticle-Catalyzed Diels-Alder Cycloadditions of
2′-Hydroxychalcones
Huan Cong, Clinton F. Becker, Sean J. Elliott, Mark W. Grinstaff, and
John A. Porco, Jr.*
Department of Chemistry and Center for Chemical Methodology and Library DeVelopment
(CMLD-BU), Boston UniVersity, Boston, Massachusetts 02215
Received March 24, 2010; E-mail: porco@bu.edu
Abstract: Metal nanoparticles are currently being employed as catalysts for a number of classical chemical
transformations. In contrast, identification of novel reactions of nanoparticles, especially toward the synthesis
of complex natural products and derivatives, is highly underdeveloped and represents a bourgeoning area
in chemical synthesis. Herein, we report silica-supported silver nanoparticles as solid, recyclable catalysts
for Diels-Alder cycloadditions of 2′-hydroxychalcones and dienes in high yield and turnover number. The
use of silver nanoparticle catalysts is further demonstrated by the total synthesis of the cytotoxic natural
product panduratin A employing a highly electron-rich dienophile and Lewis acid sensitive diene.
Scheme 1. Retrosynthetic Analysis for Panduratin A and Synthetic
Challenges
Introduction
The 21st century is observing rapid progress in the nano-
sciences including preparation, characterization, and synthetic
applications of metal nanoparticles.1 Although nanoparticles are
promising heterogeneous catalysts due to their high surface area
and unique size-dependent properties,2 they have not found
substantial applications in complex natural product synthesis,
with most examples thus far being limited to previously known
transformations.3 This is in sharp contrast to homogeneous
catalysts which are widely established and extensively used for
a broad range of reaction types.4 Accordingly, the field of metal
nanoparticle catalysis should offer opportunities for mining new
chemical reactions,5 in particular, those which enable the
synthesis of biologically important and synthetically challenging
natural products and derivatives. Herein, we describe such an
application involving the total synthesis of the bioactive
cyclohexenyl chalcone natural product panduratin A which
features silver nanoparticle (AgNP)-catalyzed Diels-Alder
cycloadditions of 2′-hydroxychalcones and dienes.
derived from highly oxygenated 2′-hydroxychalcone dieno-
philes.8 Behind the seemingly simple structure and straightfor-
ward retrosynthetic design of 1 (Scheme 1) are a number of
synthetic challenges. The poorly reactive 2′-hydroxychalcone
dienophile (cf. 2) resists traditional Lewis acid promoted
conditions9 likely due to its electron-rich nature and the tendency
of undesired cyclizations to form flavanones such as 3. In
addition, the requisite diene trans-ꢀ-ocimene (4) has been found
to undergo olefin isomerization and polymerization under acidic
Since its isolation in 1984,6 panduratin A (1) has shown
promising anticancer, anti-HIV, and anti-inflammatory activi-
ties.7 This natural product belongs to the family of prenylfla-
vonoid and related Diels-Alder natural products which are
(1) Schmid, G. Nanoparticles: From Theory to Application; Wiley-VCH:
Weinheim, 2004.
(7) For select references on biological activities of panduratin A, see: (a)
Kiat, T. S.; Pippen, R.; Yusof, R.; Ibrahim, H.; Khalid, N.; Rahman,
N. A. Bioorg. Med. Chem. Lett. 2006, 16, 3337–3340. (b) Yun, J. M.;
Kweon, M. H.; Kwon, H.; Hwang, J. K.; Mukhtar, H. Carcinogenesis
2006, 27, 1454–1464. (c) Cheenpracha, S.; Karalai, C.; Ponglimanont,
C.; Subhadhirasakul, S.; Tewtrakul, S. Bioorg. Med. Chem. 2006, 14,
1710–1714. (d) Kirana, C.; Jones, G. P.; Record, I. R.; McIntosh, G. H.
J. Nat. Med. 2007, 61, 131–137. (e) Shim, J. S.; Kwon, Y. Y.; Han,
Y. S.; Hwang, J. K. Planta Med. 2008, 74, 1446–1450. (f) Yoshikawa,
M.; Morikawa, T.; Funakoshi, K.; Ochi, M.; Pongpiriyadacha, Y.;
Matsuda, H. Heterocycles 2008, 75, 1639–1650. (g) Rukayadi, Y.;
Lee, K.; Han, S.; Yong, D.; Hwang, J. K. Antimicrob. Agents
Chemother. 2009, 53, 4529–4532.
(2) Henglein, A. Chem. ReV. 1989, 89, 1861–1873.
(3) Astruc, D. Nanoparticles and Catalysis; Wiley-VCH: Weinheim, 2007.
(4) Smith, M. B.; March, J. March’s AdVanced Organic Chemistry:
Reactions, Mechanisms, and Structure, 6th ed.; Wiley: Hoboken, NJ,
2007.
(5) For select references, see: (a) Mitsudome, T.; Arita, S.; Mori, H.;
Mizugaki, T.; Jitsukawa, K.; Kaneda, K. Angew. Chem., Int. Ed. 2008,
47, 7938–7940. (b) Shimizu, K.; Sato, R.; Satsuma, A. Angew. Chem.,
Int. Ed. 2009, 48, 3982–3986. (c) Murugadoss, A.; Goswami, P.; Paul,
A.; Chattopadhyay, A. J. Mol. Catal. A 2009, 304, 153–158. (d)
Witham, C. A.; Huang, W.; Tsung, C.; Kuhn, J. N.; Samorjai, G. A.;
Toste, F. D. Nature Chem. 2009, 2, 36–41.
(8) (a) Nomura, T. Pure Appl. Chem. 1999, 71, 1115–1118. (b) Nomura,
T. Yakugaku Zasshi 2001, 121, 535–556.
(6) Tuntiwachwuttikul, P.; Pancharoen, O.; Reutrakul, V.; Byrne, L. T.
Aust. J. Chem. 1984, 37, 449–453.
(9) Corbett, J. L.; Weavers, R. T. Synth. Commun. 2008, 38, 489–498.
9
7514 J. AM. CHEM. SOC. 2010, 132, 7514–7518
10.1021/ja102482b 2010 American Chemical Society